Dr. Volpp is the founding Director of the Center for Health Incentives and Behavioral Economics (CHIBE), Division Chief of Health Policy for the Department of Medical Ethics and Policy, and the Founders President’s Distinguished Professor of Medicine at the Perelman School of Medicine and Health Care Management at the Wharton School of the University of Pennsylvania. He has led CHIBE since its inception turning it into an entity that involves more than 90 faculty members and trainees across the University of Pennsylvania and which was 1 of 2 original NIH Centers nationally on behavioral economics and health.
Dr. Volpp’s work focuses on developing and testing innovative ways of applying insights from behavioral economics in improving patient health behavior and increasing value in the health system by influencing provider performance. He has competitively been awarded more than $70 million to lead projects with a variety of employers, insurers, health systems, and consumer companies in testing the impact of different behavioral economic strategies on behavior.
Dr. Volpp has published more than 250 articles, book chapters, and commentaries, and his work has served as the foundation for numerous widely implemented programs such as benefit design initiatives using financial incentives for smoking cessation among GE and CVS employees, a prescription refill synchronization program for Humana members, a simple health insurance plan called “Humana Simplicity”, and an ‘enhanced active choice’ approach used among tens of millions of CVS members to increase the ease of receiving automated medication refills.
Dr. Volpp’s work has been recognized by a number of career achievement awards including the Matilda White Riley Award by the Office of Social and Behavioral Science at NIH, the John Eisenberg Award from the Society of General Internal Medicine, and the Association for Clinical and Translational Science Distinguished Investigator Award for Clinical and Translational Science. Volpp is an elected member of the National Academy of Medicine, an editorial board member for the NEJM Catalyst, and a principal of the behavioral economics consulting firm VAL Health.